.
HSM financial statements
* Numbers in thousands
Year |
2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|
Capitalization * |
99 782 | 236 632 | 224 213 | 33 204 | 20 542 | 21 979 |
EV * |
97 138 | 231 070 | 198 630 | 27 917 | 17 270 | 17 270 |
Stock price ¤ |
262.5 | 444.5 | 344.4 | 44.1 | 17.15 | 18.35 |
Number of shares * |
380 | 532 | 651 | 753 | 1 198 | 1 198 |
EPS |
-18,10 | -52,64 | -43,97 | -12,99 | -11,80 | -11,80 |
Revenue * |
0 | 0 | 478 | 1 496 | 661 | 661 |
Net income * |
-6 882 | -28 024 | -28 623 | -9 781 | -14 130 | -14 130 |
Operating profit * |
-9 317 | -22 853 | -26 675 | -23 996 | -14 386 | -14 386 |
Total liabilities * |
4 057 | 14 299 | 17 973 | 4 512 | 2 676 | 2 676 |
Net debt * |
-2 644 | -5 562 | -25 583 | -4 822 | -3 240 | -3 240 |
Total assets * |
4 041 | 6 809 | 27 827 | 10 347 | 6 547 | 6 547 |
Equity * |
-16 | -7 490 | 9 854 | 5 835 | 3 871 | 3 871 |
Cash and investments * |
2 644 | 5 562 | 25 583 | 5 459 | 3 331 | 3 331 |
Over the past 10 years, the maximum capitalization of Helius Medical Technologies, Inc. is 236 632, the minimum is 20 542. Maximum net income 0, Minimum net income -28 623. The maximum price of HSM shares is 444.5, the minimum price is 17.15.
.
HSM valuation
Year |
2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|
P/E |
-14,50 | -8,44 | -7,83 | -3,39 | -1,45 | -1,56 |
P/B |
-6 162,44 | -31,59 | 22,75 | 5,69 | 5,31 | 5,68 |
P/S |
0,00 | 0,00 | 469,06 | 22,20 | 31,08 | 33,25 |
E/P |
-7% | -12% | -13% | -29% | -69% | -64% |
P/FCF |
-12,57 | -12,13 | -11,18 | -1,56 | -1,74 | -1,86 |
.
HSM profitability
Year |
2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|
ROE |
42 501% | 374% | -290% | -168% | -365% | |
ROA |
-170% | -412% | -103% | -115% | -269% | |
ROIC |
-545% | 305% | -271% | -367% | -349% |